Evidence map›Paper›PMID 26202925›Full record

ArticleLeukemia2016

Independent development of lymphoid and histiocytic malignancies from a shared early precursor.

E Waanders, K M Hebeda, E J Kamping, P J T A Groenen, A Simons, A Hoischen, M C J Jongmans, P M Hoogerbrugge, F N van Leeuwen, R P Kuiper and 1 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

E WaandersDepartment of Human Genetics, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
K M HebedaDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
E J KampingDepartment of Human Genetics, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
P J T A GroenenDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
A SimonsDepartment of Human Genetics, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
A HoischenDepartment of Human Genetics, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
M C J JongmansDepartment of Human Genetics, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
P M HoogerbruggePrincess Máxima Center for Pediatric Oncology, De Bilt, The Netherlands.
F N van LeeuwenDepartment of Pediatric Oncology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
R P KuiperDepartment of Human Genetics, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.
D M W M Te LooDepartment of Pediatric Oncology, Radboud University Medical Center and Radboud Institute for Molecular Life Sciences, Nijmegen, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsBiomarkers, TumorCase-Control StudiesCombined Modality TherapyFemaleFollow-Up StudiesHistiocytic Disorders, MalignantHumansImmunoenzyme TechniquesImmunophenotypingLymphatic MetastasisLymphoma, Large B-Cell, DiffuseMaleBiomarkers, Tumor

Identifiers

PMID26202925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.